AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ESOMEPRAZOLE 40.000 Mg ;
30 registrations across 1 African market— 30 active
Markets with ESOMEPRAZOLE 40.000 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| BIORAZO 40mg delayed release hard gelatin capsule | 🇪🇬Egypt | SAJA Pharmaceuticals Egypt - SAJA | active | — |
| Neximash 40 mg Enteric coated granules for delayed release oral suspension | 🇪🇬Egypt | Mash for pharmaceutical Industries and cosmetic - mash premiere | active | — |
| Nexium IV Powder for Solution for Injection | 🇪🇬Egypt | Astrazeneca scientific office | active | — |
| NEXIUM Gastro resistant tablet | 🇪🇬Egypt | AstraZeneca Egypt for Pharmaceutical Industries | active | — |
| AIG ESOMEPRAZOLE Hard Gelatin Capsules Containing Delayed Release Pellets | 🇪🇬Egypt | PLANET CURE | active | — |
| Esomeprazole – Eva Pharma 40 mg Powder for Solution for I.V Infusion | 🇪🇬Egypt | Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharma | active | — |
| Esogerdazole 40mg DR Delayed release enteric coated pellets in hard gelatin capsule | 🇪🇬Egypt | al rowad for pharmaceutical industries | active | — |
| Esopiroxan 40mg Delayed release enteric coated pellets in hard gelatin capsule | 🇪🇬Egypt | al andalous for pharmaceutical industries | active | — |
| Esomeprazole – Eva Pharma Enteric Coated Tablet | 🇪🇬Egypt | Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharma | active | — |
| PACIFIAL 40 mg Hard Gelatin Capsules Containing Delayed Release Pellets | 🇪🇬Egypt | SIGMA PHARMACEUTICAL INDUSTRIES | active | — |
| PACIFIAL 40 mg Hard Gelatin Capsules Containing Delayed Release Pellets | 🇪🇬Egypt | SIGMA PHARMACEUTICAL INDUSTRIES | active | — |
| AIG ESOMEPRAZOLE Hard Gelatin Capsules Containing Delayed Release Pellets | 🇪🇬Egypt | PLANET CURE | active | — |
| Esomeprazole – Eva Pharma 40 mg Powder for Solution for I.V Infusion | 🇪🇬Egypt | Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharma | active | — |
| Esogerdazole 40mg DR Delayed release enteric coated pellets in hard gelatin capsule | 🇪🇬Egypt | al rowad for pharmaceutical industries | active | — |
| Esopiroxan 40mg Delayed release enteric coated pellets in hard gelatin capsule | 🇪🇬Egypt | al andalous for pharmaceutical industries | active | — |
| Esomeprazole – Eva Pharma Enteric Coated Tablet | 🇪🇬Egypt | Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharma | active | — |
| Esmorap® 40 mg Delayed Release Granules for Oral Suspension | 🇪🇬Egypt | AUG Pharma | active | — |
| Esmorap Powder for Solution for I.V Infusion | 🇪🇬Egypt | AUG Pharma | active | — |
| ESMORAP 40 mg Hard Gelatin Capsules | 🇪🇬Egypt | AUG Pharma | active | — |
| STOMOPRAL 40 mg Hard gelatin capsules containing enteric coated pellets | 🇪🇬Egypt | FUTURE PHARMACEUTICAL INDUSTRIES-EGYPT | active | — |
| NEXIUM Gastro resistant tablet | 🇪🇬Egypt | AstraZeneca Egypt for Pharmaceutical Industries | active | — |
| Esmorap Powder for Solution for I.V Infusion | 🇪🇬Egypt | AUG Pharma | active | — |
| Esmorap® 40 mg Delayed Release Granules for Oral Suspension | 🇪🇬Egypt | AUG Pharma | active | — |
| Nexium IV Powder for Solution for Injection | 🇪🇬Egypt | Astrazeneca scientific office | active | — |
| ESMORAP 40 mg Hard Gelatin Capsules | 🇪🇬Egypt | AUG Pharma | active | — |
| Megaprazole 40 mg Lyophilized Powder for Reconstitution for I.V Infusion | 🇪🇬Egypt | Chemipharm Pharmaceutical Industries | active | — |
| Atmiprazole 40 mg Hard Gelatin Capsules Containing Delayed Release Pellets | 🇪🇬Egypt | ATM Pharmaceutical Industries, Import and Export | active | — |
| Exeedogast Delayed release capsule containing enteric coated pellets | 🇪🇬Egypt | Naplex Pharmaceuticals | active | — |
| KLEMAZICE 40mg Hard Gelatin Capsules Containing Delayed Release Pellets | 🇪🇬Egypt | Spimaco Misr for pharmaceutical industries | active | — |
| STOMOPRAL 40 mg Hard gelatin capsules containing enteric coated pellets | 🇪🇬Egypt | FUTURE PHARMACEUTICAL INDUSTRIES-EGYPT | active | — |
ESOMEPRAZOLE 40.000 Mg ; in Africa — Regulatory Overview
ESOMEPRAZOLE 40.000 Mg ; is registered across 1 African markets with 30 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 30 registrations, 30 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.